Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment - Van Audenaerde - 2020 - Clinical & Translational Immunology - Wiley Online Library
Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity | PNAS
Frontiers | Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology
With the High Potential in Cancer Immunotherapy, CD40 Is Triggering Attention - Cusabio
CD40-agonist: A new avenue for immunotherapy combinations in cholangiocarcinoma - Journal of Hepatology
CD40 Bioassay
The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy - Parker Institute for Cancer Immunotherapy
Frontiers | CD40L and Its Receptors in Atherothrombosis—An Update
Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation
First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies - Irenaeus - 2019 - International Journal of Cancer - Wiley Online Library
InVivoMAb anti-mouse CD40 | Bio X Cell
Anti-CD40 Antibody - Pipeline Insight, 2022
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma | Nature Communications
CD40 therapy and surgery: a potential immunologic partnership. - Abstract - Europe PMC
IJMS | Free Full-Text | FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text
Frontiers | Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint - ScienceDirect
Cancers | Free Full-Text | Agonistic CD40 Antibodies in Cancer Treatment
Anti-CD40 clinical trials* against pancreatic cancer | Download Table
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text
Side effects of CD40 agonistic antibodies versus fusion molecules. | Download Scientific Diagram
Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement - ScienceDirect
![PDF] Agonistic CD40 Antibodies and Cancer Therapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7cb235318895039cd45eb055391de568e99105c1/2-Table1-1.png "PDF] Agonistic CD40 Antibodies and Cancer Therapy | Semantic Scholar")
PDF] Agonistic CD40 Antibodies and Cancer Therapy | Semantic Scholar
